NCT00469014 Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00462332 Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00455312 Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA Status COMPLETED Phase PHASE2/PHASE3
NCT00452374 Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL Status COMPLETED Phase PHASE1/PHASE2
NCT00448019 FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE2
NCT00429572 Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00429416 Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT00429026 Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Status TERMINATED Phase PHASE2
NCT00427336 Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia Status COMPLETED Phase NA
NCT00416910 Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE3
NCT00416884 Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML Status TERMINATED Phase PHASE2
NCT00412360 Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Status COMPLETED Phase PHASE3
NCT00410163 Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients Status COMPLETED Phase PHASE2
NCT00408447 Stem Cell Transplant in Sickle Cell Disease and Thalassemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00402558 Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE1
NCT00385788 Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease Status COMPLETED Phase PHASE2
NCT00382694 Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients Status UNKNOWN Phase PHASE2
NCT00381004 FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2